Myriad Genetics Total Assets 2006-2019 | MYGN

Myriad Genetics total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
Myriad Genetics Annual Total Assets
(Millions of US $)
2018 $1,174
2017 $1,209
2016 $881
2015 $766
2014 $824
2013 $804
2012 $691
2011 $611
2010 $594
2009 $466
2008 $499
2007 $376
2006 $277
2005 $159
Myriad Genetics Quarterly Total Assets
(Millions of US $)
Q3 2019 $1,557
Q2 2018 $1,557
Q1 2018 $1,574
Q4 2018 $1,175
Q3 2018 $1,219
Q2 2017 $1,229
Q1 2017 $1,228
Q4 2017 $1,209
Q3 2017 $1,268
Q2 2016 $1,276
Q1 2016 $1,271
Q4 2016 $881
Q3 2016 $868
Q2 2015 $872
Q1 2015 $787
Q4 2015 $766
Q3 2015 $779
Q2 2014 $782
Q1 2014 $809
Q4 2014 $824
Q3 2014 $816
Q2 2013 $757
Q1 2013 $782
Q4 2013 $804
Q3 2013 $729
Q2 2012 $718
Q1 2012 $703
Q4 2012 $691
Q3 2012 $699
Q2 2011 $661
Q1 2011 $620
Q4 2011 $611
Q3 2011 $557
Q2 2010 $594
Q1 2010 $611
Q4 2010 $594
Q3 2010 $590
Q2 2009 $540
Q1 2009 $494
Q4 2009 $466
Q3 2009 $620
Q2 2008 $574
Q1 2008 $531
Q4 2008 $499
Q3 2008 $391
Q2 2007 $384
Q1 2007 $373
Q4 2007 $376
Q3 2007 $362
Q2 2006 $262
Q1 2006 $263
Q4 2006 $277
Q3 2006 $278
Q2 2005 $285
Q1 2005 $150
Q4 2005 $159
Q3 2005 $161
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.775B $0.773B
Myriad Genetics, Inc. is focused on revolutionizing patient care through the discovery, development and marketing of transformative molecular diagnostic tests that address pressing clinical needs across multiple medical specialties. Myriad is the pioneer and leader in molecular diagnostics, offering innovative products that transform patients' lives. These products include leading molecular diagnostic tests for hereditary cancer, urological cancer, lung cancer, autoimmune disorders and other diseases. Myriad has invested heavily in educating patients and healthcare professionals about the role genes and proteins play in disease. Myriad's hereditary cancer genetic testing, which helps healthcare professionals better manage and tailor medical care. Myriad is expanding their reach and increasing their impact on patient care by introducing new molecular diagnostic and companion diagnostic tests for a growing number of diseases.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $110.770B 12.52
Gilead Sciences (GILD) United States $86.948B 10.56
Celgene (CELG) United States $68.516B 11.61
Illumina (ILMN) United States $51.134B 59.26
Vertex Pharmaceuticals (VRTX) United States $45.574B 55.09
Biogen (BIIB) United States $45.179B 8.58
Regeneron Pharmaceuticals (REGN) United States $33.507B 15.75
Alexion Pharmaceuticals (ALXN) United States $27.440B 15.53
Incyte (INCY) United States $18.073B 73.29
BioMarin Pharmaceutical (BMRN) United States $15.312B 0.00
Exact Sciences (EXAS) United States $14.941B 0.00
Seattle Genetics (SGEN) United States $11.799B 0.00
Array BioPharma (ARRY) United States $10.329B 0.00
Sarepta Therapeutics (SRPT) United States $9.812B 0.00
QIAGEN (QGEN) Netherlands $9.120B 29.96
Bio-Rad Laboratories (BIO.B) United States $8.674B 45.98
Guardant Health (GH) United States $7.937B 0.00
Bio-Techne Corp (TECH) United States $7.858B 53.62
Alnylam Pharmaceuticals (ALNY) United States $7.779B 0.00
Bluebird Bio (BLUE) United States $6.522B 0.00
Galapagos (GLPG) Belgium $6.449B 0.00
Amarin (AMRN) Ireland $6.415B 0.00
Exelixis (EXEL) United States $6.268B 15.98
BeiGene (BGNE) Cayman Islands $5.435B 0.00
Ascendis Pharma (ASND) Denmark $5.296B 0.00
Moderna (MRNA) United States $5.179B 0.00
Blueprint Medicines (BPMC) United States $4.778B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.304B 0.00
Spark Therapeutics (ONCE) United States $3.916B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.738B 0.00
Repligen (RGEN) United States $3.733B 93.00
Mirati Therapeutics (MRTX) United States $3.687B 0.00
China Biologic Products (CBPO) China $3.664B 23.27
Ultragenyx Pharmaceutical (RARE) United States $3.581B 0.00
Alkermes (ALKS) Ireland $3.490B 0.00
Allogene Therapeutics (ALLO) United States $3.425B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.185B 0.00
Global Blood Therapeutics (GBT) United States $3.176B 0.00
UniQure (QURE) Netherlands $2.949B 0.00
Arena Pharmaceuticals (ARNA) United States $2.895B 5.88
Amicus Therapeutics (FOLD) United States $2.869B 0.00
Lion Biotechnologies (IOVA) United States $2.767B 0.00
Medicines (MDCO) United States $2.648B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.550B 0.00
Reata Pharmaceuticals (RETA) United States $2.538B 0.00
Immunomedics (IMMU) United States $2.536B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.475B 0.00
Emergent Biosolutions (EBS) United States $2.397B 20.82
Halozyme Therapeutics (HALO) United States $2.395B 0.00
NeoGenomics (NEO) United States $2.267B 148.44
Ligand Pharmaceuticals (LGND) United States $2.247B 18.61
Akcea Therapeutics (AKCA) United States $2.225B 0.00
MyoKardia (MYOK) United States $2.211B 0.00
Acceleron Pharma (XLRN) United States $2.140B 0.00
Insmed (INSM) United States $2.022B 0.00
Genomic Health (GHDX) United States $2.013B 42.75
Biohaven Pharmaceutical Holding (BHVN) United States $1.951B 0.00
REGENXBIO (RGNX) United States $1.943B 0.00
Allakos (ALLK) United States $1.917B 0.00
Denali Therapeutics (DNLI) United States $1.886B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.881B 0.00
AnaptysBio (ANAB) United States $1.821B 0.00
Audentes Therapeutics (BOLD) United States $1.769B 0.00
Cambrex (CBM) United States $1.470B 18.59
Nabriva Therapeutics AG (NBRV) Ireland $1.464B 0.00
Innoviva (INVA) United States $1.452B 4.02
Apellis Pharmaceuticals (APLS) United States $1.447B 0.00
Gossamer Bio (GOSS) United States $1.404B 0.00
Alector (ALEC) United States $1.345B 0.00
Coherus BioSciences (CHRS) United States $1.342B 0.00
Fate Therapeutics (FATE) United States $1.317B 0.00
Aimmune Therapeutics (AIMT) United States $1.262B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.252B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.229B 0.00
Eidos Therapeutics (EIDX) United States $1.213B 0.00
Athenex (ATNX) United States $1.207B 0.00
Epizyme (EPZM) United States $1.185B 0.00
Sangamo Therapeutics (SGMO) United States $1.143B 0.00
Rubius Therapeutics (RUBY) United States $1.137B 0.00
Editas Medicine (EDIT) United States $1.132B 0.00
CORTEXYME INC (CRTX) United States $1.127B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.086B 0.00
Atara Biotherapeutics (ATRA) United States $1.017B 0.00
Codexis (CDXS) United States $0.998B 0.00
RA PHARMCTL INC (RARX) United States $0.992B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.982B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.980B 0.00
WAVE Life Sciences (WVE) Singapore $0.957B 0.00
G1 THERAPEUTICS (GTHX) United States $0.918B 0.00
NGM Biopharmaceuticals (NGM) United States $0.916B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.916B 0.00
Twist Bioscience (TWST) United States $0.891B 0.00
ANI Pharmaceuticals (ANIP) United States $0.891B 15.80
Principia Biopharma (PRNB) United States $0.858B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.851B 0.00
Retrophin (RTRX) United States $0.844B 0.00
Axsome Therapeutics (AXSM) United States $0.808B 0.00
Cara Therapeutics (CARA) United States $0.788B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.778B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.776B 36.65
Clovis Oncology (CLVS) United States $0.771B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.769B 0.00
Intra-Cellular Therapies (ITCI) United States $0.767B 0.00
GENFIT Unsponsored ADR (GNFT) France $0.766B 0.00
Adverum Biotechnologies (ADVM) United States $0.746B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.746B 0.00
Vericel (VCEL) United States $0.738B 0.00
Kura Oncology (KURA) United States $0.717B 0.00
Arvinas (ARVN) United States $0.711B 0.00
MeiraGTx Holdings (MGTX) United States $0.710B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.691B 0.00
Precision BioSciences (DTIL) United States $0.690B 0.00
Intellia Therapeutics (NTLA) United States $0.687B 0.00
Myovant Sciences (MYOV) United Kingdom $0.669B 0.00
Stemline Therapeutics (STML) United States $0.661B 0.00
Zymeworks (ZYME) Canada $0.647B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.642B 0.00
Zealand Pharma (ZEAL) Denmark $0.640B 7.48
Cytokineticsorporated (CYTK) United States $0.637B 0.00
Heska (HSKA) United States $0.629B 64.44
Cellectis (CLLS) France $0.616B 0.00
Viking Therapeutics (VKTX) United States $0.602B 0.00
Anika Therapeutics (ANIK) United States $0.575B 19.65
Milestone Pharmaceuticals (MIST) Canada $0.549B 0.00
Puma Biotechnology (PBYI) United States $0.541B 0.00
Scholar Rock Holding (SRRK) United States $0.531B 0.00
DBV Technologies (DBVT) France $0.510B 0.00
Revance Therapeutics (RVNC) United States $0.506B 0.00
CytomX Therapeutics (CTMX) United States $0.504B 0.00
BeyondSpring (BYSI) United States $0.504B 0.00
ObsEva SA (OBSV) Switzerland $0.498B 0.00
UROGEN PHARMA (URGN) United States $0.487B 0.00
Magenta Therapeutics (MGTA) United States $0.466B 0.00
Mesoblast (MESO) Australia $0.460B 0.00
Sorrento Therapeutics (SRNE) United States $0.453B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.453B 0.00
Synthorx (THOR) United States $0.443B 0.00
Kodiak Sciences (KOD) United States $0.432B 0.00
Kaleido Biosciences (KLDO) $0.424B 0.00
MediciNova (MNOV) United States $0.421B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.418B 0.00
Arcus Biosciences (RCUS) United States $0.414B 0.00
Krystal Biotech (KRYS) United States $0.412B 0.00
Replimune (REPL) United States $0.407B 0.00
BioDelivery Sciences (BDSI) United States $0.405B 0.00
Provention Bio (PRVB) United States $0.404B 0.00
Prothena (PRTA) Ireland $0.399B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.393B 0.00
Agenus (AGEN) United States $0.392B 0.00
Gritstone Oncology (GRTS) United States $0.390B 0.00
Albireo Pharma (ALBO) United States $0.390B 0.00
AC Immune SA (ACIU) Switzerland $0.388B 24.96
Biofrontera AG Sponsored ADR (BFRA) Germany $0.374B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Acorda Therapeutics (ACOR) United States $0.369B 6.49
Adaptimmune Therapeutics (ADAP) United Kingdom $0.366B 0.00
UNITY Biotechnology (UBX) $0.365B 0.00
Senesco Technologies (ELOX) United States $0.360B 0.00
PDL BioPharma (PDLI) United States $0.359B 8.57
Stealth BioTherapeutics Sponsored ADR (MITO) United States $0.358B 0.00
NEXTCURE INC (NXTC) United States $0.340B 0.00
LogicBio Therapeutics (LOGC) United States $0.337B 0.00
ResTORbio (TORC) United States $0.332B 0.00
PHASEBIO PHARMA (PHAS) United States $0.326B 0.00
Kindred Biosciences (KIN) United States $0.323B 0.00
AVROBIO (AVRO) United States $0.319B 0.00
Merus (MRUS) Netherlands $0.315B 0.00
Cyclerion Therapeutics (CYCN) United States $0.315B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.309B 0.00
Geron (GERN) United States $0.300B 0.00
Syros Pharmaceuticals (SYRS) United States $0.292B 0.00
Protagonist Therapeutics (PTGX) United States $0.278B 0.00
XBiotech (XBIT) United States $0.277B 0.00
Sutro Biopharma (STRO) United States $0.273B 0.00
Athersys (ATHX) United States $0.267B 0.00
Palatin Technologies (PTN) United States $0.266B 0.00
Evelo Biosciences (EVLO) United States $0.261B 0.00
Cellular Biomedicine (CBMG) United States $0.260B 0.00
Inovio Pharmaceuticals (INO) United States $0.259B 0.00
Dynavax Technologies (DVAX) United States $0.258B 0.00
BICYCLE THERAPT (BCYC) United Kingdom $0.258B 0.00
Constellation Pharmaceuticals (CNST) United States $0.258B 0.00
Chiasma (CHMA) United States $0.254B 0.00
Abeona Therapeutics (ABEO) United States $0.246B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.245B 0.00
Urovant Sciences (UROV) United States $0.242B 0.00
Synlogic (SYBX) United States $0.239B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.236B 0.00
Five Prime Therapeutics (FPRX) United States $0.236B 0.00
Neothetics (EVFM) United States $0.231B 0.00
Celcuity (CELC) United States $0.230B 0.00
Kadmon Holdings (KDMN) United States $0.229B 0.00
ChromaDex (CDXC) United States $0.228B 0.00
MannKind (MNKD) United States $0.228B 0.00
AXCELLA HEALTH (AXLA) United States $0.226B 0.00
Kamada (KMDA) Israel $0.220B 8.55
Cerecor (CERC) United States $0.219B 0.00
Avid Bioservices (CDMO) United States $0.219B 0.00
Cel-Sci (CVM) United States $0.217B 0.00
Pfenex (PFNX) United States $0.216B 0.00
Spero Therapeutics (SPRO) United States $0.216B 0.00
ADMA Biologics Inc (ADMA) United States $0.216B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.212B 0.00
IDEAYA BIOSCI (IDYA) United States $0.212B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.212B 0.00
Affimed (AFMD) Germany $0.206B 0.00
Enochian BioSciences (ENOB) United States $0.201B 0.00
Mersana Therapeutics (MRSN) United States $0.195B 0.00
Enzo Biochem (ENZ) United States $0.195B 0.00
Kala Pharmaceuticals (KALA) United States $0.188B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.187B 0.00
Strongbridge Biopharma (SBBP) United States $0.185B 10.69
Arsanis (XFOR) United States $0.183B 0.00
Solid Biosciences (SLDB) United States $0.182B 0.00
Compugen (CGEN) Israel $0.181B 0.00
Gamida Cell (GMDA) Israel $0.180B 0.00
HOOKIPA PHARMA (HOOK) United States $0.177B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.175B 0.00
Dyadic (DYAI) United States $0.173B 0.00
CorMedix Inc (CRMD) United States $0.171B 0.00
BioXcel Therapeutics (BTAI) United States $0.171B 0.00
Anavex Life Sciences (AVXL) United States $0.165B 0.00
OvaScience (MLND) United States $0.165B 0.00
BioTime (BTX) United States $0.165B 11.00
OSMOTICA PHARM (OSMT) United States $0.162B 0.00
Liquidia Technologies (LQDA) United States $0.160B 0.00
Intec Pharma (NTEC) Israel $0.157B 0.00
Aduro Biotech (ADRO) United States $0.155B 0.00
Menlo Therapeutics (MNLO) United States $0.154B 0.00
APPLIED THERAPT (APLT) United States $0.153B 0.00
Mustang Bio (MBIO) United States $0.153B 0.00
Checkpoint Therapeutics (CKPT) United States $0.153B 0.00
XOMA (XOMA) United States $0.153B 0.00
Cue Biopharma (CUE) United States $0.151B 0.00
TREVI THERAPTCS (TRVI) United States $0.150B 0.00
Kezar Life Sciences (KZR) United States $0.150B 0.00
TOCAGEN INC (TOCA) United States $0.145B 0.00
SESEN BIO, INC (SESN) United States $0.143B 0.00
Verastem (VSTM) United States $0.134B 0.00
Celyad SA (CYAD) Belgium $0.130B 0.00
Eton Pharmaceuticals (ETON) United States $0.130B 0.00
Axovant Sciences (AXGT) United States $0.128B 0.00
Fortress Biotech (FBIO) United States $0.121B 0.00
Novavax (NVAX) United States $0.120B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.119B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.118B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.116B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.116B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.114B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.114B 0.00
VolitionRX (VNRX) Singapore $0.112B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.112B 0.00
NantKwest (NK) United States $0.112B 0.00
Aptose Biosciences (APTO) Canada $0.111B 0.00
Seres Therapeutics (MCRB) United States $0.107B 0.00
INmune Bio (INMB) United States $0.107B 0.00
Aptinyx (APTX) United States $0.106B 0.00
Equillium (EQ) United States $0.105B 0.00
Trevena (TRVN) United States $0.103B 0.00
Allena Pharmaceuticals (ALNA) United States $0.102B 0.00
Arbutus Biopharma (ABUS) Canada $0.101B 0.00
Selecta Biosciences (SELB) United States $0.098B 0.00
Catalyst Biosciences (CBIO) United States $0.089B 0.00
InflaRx (IFRX) Germany $0.085B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.083B 0.00
Idera Pharmaceuticals (IDRA) United States $0.083B 0.00
Pluristem Therapeutics (PSTI) Israel $0.083B 0.00
Unum Therapeutics (UMRX) United States $0.081B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.081B 0.00
Cohbar (CWBR) United States $0.077B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.076B 0.00
Signal Genetics (MGEN) United States $0.075B 0.00
OVID THERAPEUTC (OVID) United States $0.075B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.074B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.074B 0.00
Applied Genetic Technologies (AGTC) United States $0.073B 40.40
VTv Therapeutics (VTVT) United States $0.071B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.071B 0.00
Cocrystal Pharma (COCP) United States $0.070B 73.33
ARAVIVE, INC (ARAV) United States $0.067B 0.00
Orgenesis (ORGS) United States $0.066B 0.00
Prima BioMed (IMMP) Australia $0.066B 0.00
VBI Vaccines (VBIV) United States $0.065B 0.00
Alimera Sciences (ALIM) United States $0.065B 0.00
Hoth Therapeutics (HOTH) United States $0.065B 0.00
Protalix BioTherapeutics (PLX) Israel $0.063B 0.00
ScPharmaceuticals (SCPH) United States $0.063B 0.00
Alcobra (ARCT) United States $0.062B 0.00
Vaccinex (VCNX) United States $0.059B 0.00
NewLink Genetics (NLNK) United States $0.059B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.059B 0.00
Eyenovia (EYEN) United States $0.057B 0.00
Organovo Holdings (ONVO) United States $0.056B 0.00
Ophthotech (ISEE) United States $0.055B 0.00
Moleculin Biotech (MBRX) United States $0.054B 0.00
Oncobiologics (OTLK) United States $0.054B 0.00
Proteostasis Therapeutics (PTI) United States $0.054B 0.00
Zosano Pharma (ZSAN) United States $0.052B 0.00
Curis (CRIS) United States $0.052B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.051B 0.00
AEterna Zentaris (AEZS) United States $0.050B 0.00
AquaBounty Technologies (AQB) United States $0.048B 0.00
Apricus Biosciences (SEEL) United States $0.048B 0.00
Bellerophon Therapeutics (BLPH) United States $0.046B 0.00
DiaMedica Therapeutics (DMAC) United States $0.046B 0.00
Vascular Biogenics (VBLT) Israel $0.043B 0.00
Entera Bio (ENTX) Israel $0.043B 0.00
Cidara Therapeutics (CDTX) United States $0.041B 0.00
Aptevo Therapeutics (APVO) United States $0.041B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.041B 0.00
Clearside Biomedical (CLSD) United States $0.040B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.040B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.039B 0.00
Celsion (CLSN) United States $0.039B 0.00
AZURRX BIOPHARM (AZRX) United States $0.037B 0.00
Evogene (EVGN) Israel $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.037B 0.00
VIVUS (VVUS) United States $0.037B 0.00
Leap Therapeutics (LPTX) United States $0.036B 0.00
Oncolytics Biotech (ONCY) Canada $0.035B 0.00
Anchiano Therapeutics Sponsored ADR (ANCN) Israel $0.034B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.034B 0.00
VistaGen Therapeutics (VTGN) United States $0.034B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.033B 0.00
Aytu Bioscience (AYTU) United States $0.032B 0.00
Edge Therapeutics (PDSB) United States $0.031B 0.00
Caladrius Biosciences (CLBS) United States $0.030B 0.00
Sophiris Bio (SPHS) United States $0.029B 0.00
Bionano Genomics (BNGO) United States $0.029B 0.00
GTx (ONCT) United States $0.027B 0.00
Bison Capital Acquisition (XYN) China $0.026B 0.00
Oragenics (OGEN) United States $0.022B 0.00
GENPREX INC (GNPX) United States $0.022B 0.00
Titan Pharmaceuticals (TTNP) United States $0.021B 0.00
Rexahn Pharmaceuticals (REXN) United States $0.021B 0.00
Adial Pharmaceuticals (ADIL) United States $0.020B 0.00
Histogenics (HSGX) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Vical (VICL) United States $0.019B 0.00
TRACON Pharmaceuticals (TCON) United States $0.019B 0.00
OncoSec Medical (ONCS) United States $0.018B 0.00
Cleveland BioLabs (CBLI) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.018B 0.00
Novelion Therapeutics (NVLN) Canada $0.016B 0.00
ATyr Pharma (LIFE) United States $0.016B 0.00
IBio (IBIO) United States $0.016B 0.00
Aileron Therapeutics (ALRN) United States $0.013B 0.00
Gemphire Therapeutics (GEMP) United States $0.013B 0.00
TrovaGene (TROV) United States $0.013B 0.00
Motif Bio Plc (MTFB) United States $0.013B 0.00
Novogen (KZIA) Australia $0.013B 0.00
Advaxis (ADXS) United States $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
Soligenix (SNGX) United States $0.012B 0.00
IMMURON LTD (IMRN) Australia $0.011B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
RestorGenex (DFFN) United States $0.010B 0.00
Vital Therapies (IMUX) United States $0.010B 0.00
Dare Bioscience (DARE) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.010B 0.00
Flex Pharma (FLKS) United States $0.009B 0.00
Proteon Therapeutics (PRTO) United States $0.009B 0.00
Therapix Biosciences (TRPX) Israel $0.009B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
Hemispherx BioPharma (HEB) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.008B 0.00
BioPharmX (BPMX) United States $0.008B 0.00
Neuralstem (CUR) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
AmpliPhi Biosciences (ARMP) United States $0.007B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.006B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.004B 0.00
Galena Biopharma (SLS) United States $0.004B 0.00
Stellar Biotechnologies (EDSA) United States $0.003B 0.00
Cellect Biotechnology (APOP) Israel $0.003B 0.00
Horizon Pharma Public (HZNP) Ireland $0.000B 0.00